Close Menu

NEW YORK – Pillar Biosciences said today that it has signed a comarketing agreement with China's MGI Tech for its Onco/Reveal next-generation sequencing panels.

Under the terms of the agreement, MGI, which markets the MGISP-960 and -100 automated high-throughput library prep systems, will market the Pillar panels to its sequencing customers outside the US.

"With MGI's sample prep automation, the hands-on time for our simplified library prep workflows has reached an unprecedented level of efficiency," Pillar CEO Gang Song said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.